Business Description
Fine Foods & Pharmaceuticals NTM SpA
ISIN : IT0005215329
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 2.05 | |||||
Interest Coverage | 2.5 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.5 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | -13.1 | |||||
3-Year Book Growth Rate | -5.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.66 | |||||
9-Day RSI | 38.29 | |||||
14-Day RSI | 41.06 | |||||
6-1 Month Momentum % | 0.47 | |||||
12-1 Month Momentum % | 12.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 0.95 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 93.53 | |||||
Days Sales Outstanding | 62.24 | |||||
Days Payable | 70.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.49 | |||||
Dividend Payout Ratio | 0.65 | |||||
3-Year Dividend Growth Rate | -5.9 | |||||
Forward Dividend Yield % | 1.49 | |||||
5-Year Yield-on-Cost % | 1.49 | |||||
3-Year Average Share Buyback Ratio | -2.5 | |||||
Shareholder Yield % | 25.09 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 29.46 | |||||
Operating Margin % | 4.46 | |||||
Net Margin % | 1.06 | |||||
FCF Margin % | 7.08 | |||||
ROE % | 2.03 | |||||
ROA % | 1.01 | |||||
ROIC % | 3.28 | |||||
3-Year ROIIC % | 10.46 | |||||
ROC (Joel Greenblatt) % | 5.68 | |||||
ROCE % | 5.09 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 78.68 | |||||
Forward PE Ratio | 15.31 | |||||
PE Ratio without NRI | 44.84 | |||||
Price-to-Owner-Earnings | 8.51 | |||||
PS Ratio | 0.83 | |||||
PB Ratio | 1.59 | |||||
Price-to-Tangible-Book | 1.69 | |||||
Price-to-Free-Cash-Flow | 11.66 | |||||
Price-to-Operating-Cash-Flow | 5.11 | |||||
EV-to-EBIT | 26.89 | |||||
EV-to-EBITDA | 8.05 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-FCF | 14.13 | |||||
Price-to-Graham-Number | 1.8 | |||||
Earnings Yield (Greenblatt) % | 3.73 | |||||
FCF Yield % | 8.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fine Foods & Pharmaceuticals NTM SpA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 247.187 | ||
EPS (TTM) (€) | 0.106 | ||
Beta | 0 | ||
Volatility % | 20.07 | ||
14-Day RSI | 41.06 | ||
14-Day ATR (€) | 0.097417 | ||
20-Day SMA (€) | 8.307 | ||
12-1 Month Momentum % | 12.07 | ||
52-Week Range (€) | 7.54 - 9.2 | ||
Shares Outstanding (Mil) | 24.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fine Foods & Pharmaceuticals NTM SpA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fine Foods & Pharmaceuticals NTM SpA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fine Foods & Pharmaceuticals NTM SpA Frequently Asked Questions
What is Fine Foods & Pharmaceuticals NTM SpA(FRA:9S5)'s stock price today?
When is next earnings date of Fine Foods & Pharmaceuticals NTM SpA(FRA:9S5)?
Does Fine Foods & Pharmaceuticals NTM SpA(FRA:9S5) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |